Molecular genetics of radiographically defined de novo glioblastoma multiforme
- 1 December 2000
- journal article
- research article
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 26 (6) , 544-552
Abstract
Glioblastoma multiforme (GBM) represents the final endpoint of anaplastic progression in astrocytomas. GBM which arise without clinical evidence of a prior low‐grade astrocytoma (LGA) have been designated de novo GBM, and are thought to develop rapidly from initial tumour formation. However, a purely clinical definition of de novo GBM does not exclude a long‐standing, asymptomatic low‐grade tumour. This study therefore sought to determine the genetic features of a unique group of cases in which GBMs were documented to have arisen radiographically in defined period of time (radiographically defined de novo GBM). Clinical and genetic features were examined in a group of 11 patients with a histological diagnosis of high‐grade astrocytoma at first biopsy and radiographically defined de novo GBM. The mean age of the patients at tumour diagnosis was 62 years (range 32–87). Six of 11 tumours arose in the temporal lobes. Eight of 11 tumours had epidermal growth factor receptor (EGFR) overexpression, and EGFR gene amplification was found in five of the six analysed cases. Overexpression of p53 was observed in only one tumour, and a TP53 mutation was present in this case. p16 immunostaining was undetectable in 10 cases, and homozygous deletion of CDKN2A was observed in four of the six studied tumours. pRb expression was lost in four tumours. Mutations in the PTEN gene were detected in two of six cases. The results in this unique group of cases confirms the prior hypothesis that the profile of genetic alterations in de novo GBM is distinct from that of GBM arising from a known LGA, and that these specific genetic pathways promote the rapid development of GBM.Keywords
This publication has 23 references indexed in Scilit:
- Primary and secondary glioblastomas: From concept to clinical diagnosisNeuro-Oncology, 1999
- PTEN mutations in gliomas and glioneuronal tumorsOncogene, 1998
- Molecular Genetic Correlates of p16, cdk4, and pRb Immunohistochemistry in GlioblastomasJournal of Neuropathology & Experimental Neurology, 1998
- Association of EGFR Gene Amplification and CDKN2 (p16/MTS1) Gene Deletion in Glioblastoma MultiformeBrain Pathology, 1997
- A Molecular Genetic Model of Astrocytoma HistopathologyBrain Pathology, 1997
- The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated SignalingJournal of Biological Chemistry, 1997
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumorsJournal of Neurosurgery, 1994
- The New WHO Classification of Brain TumoursBrain Pathology, 1993
- Amplification of Epidermal Growth Factor Receptor Gene in Gliomas: Histopathology and PrognosisJournal of Neuropathology & Experimental Neurology, 1992